Download
https://www.ndtvprofit.com/business/investors-flee-pharma-giants-as-zantac-cancer-trials-approach?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The knee-jerk reaction to the Zantac litigation is “somewhat overdone”, analysts say.
Share